Literature DB >> 25337300

Systemic lymphoma arising from hydroa vacciniforme-like lymphoma: report of two cases with review of literature.

Yu-Qiong Yang1, Lei Fan1, Li Wang1, Ji Xu1, Run Zhang1, Zheng Ge1, Jian-Yong Li1, Wei Xu1.   

Abstract

Hydroa vacciniforme-like lymphoma (HVLL) is an extremely rare lymphoma described in children that occurs mainly in Asia and Latin American countries. It is an Epstein-Barr virus (EBV)-positive lymphoproliferative disease (LPD) characterized by a monoclonal proliferation of T or NK cells. In this study, we report the clinical and pathological features of two Chinese patients with HVLL showed T-cell phenotype expressing CD4. The two patients generally presented with similar clinical histories of waxing and waning ulcerative blistering lesions for ten years or more until progression to systemic lymphoma. One patient died two months after progression and another is alive with disease. In the two cases, persistence infection of EBV may be attributed to the disease progression, and systemic lymphoma arising from HVLL behaves in an aggressive fashion and is predisposing to chemotherapeutic agent resistance.

Entities:  

Keywords:  Epstein-Barr virus infections; Hydroa vacciniforme; lymphoma

Mesh:

Substances:

Year:  2014        PMID: 25337300      PMCID: PMC4203271     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  15 in total

1.  Hydroa vacciniforme-like cutaneous T-cell lymphoma: clinicopathologic and immunohistochemical study of 12 cases.

Authors:  Martin Sangueza; Jose Antonio Plaza
Journal:  J Am Acad Dermatol       Date:  2013-03-28       Impact factor: 11.527

2.  Application of flow cytometric in situ hybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases.

Authors:  Shinji Kawabe; Yoshinori Ito; Kensei Gotoh; Seiji Kojima; Kimikazu Matsumoto; Tomohiro Kinoshita; Seiko Iwata; Yukihiro Nishiyama; Hiroshi Kimura
Journal:  Cancer Sci       Date:  2012-05-15       Impact factor: 6.716

Review 3.  Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru.

Authors:  Carlos Barrionuevo; Virginia M Anderson; Eduardo Zevallos-Giampietri; Mayer Zaharia; Oscar Misad; Francisco Bravo; Héctor Cáceres; Luis Taxa; Marco T Martínez; Antonio Wachtel; Miguel A Piris
Journal:  Appl Immunohistochem Mol Morphol       Date:  2002-03

4.  EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.

Authors:  Hiroshi Kimura; Yoshinori Ito; Shinji Kawabe; Kensei Gotoh; Yoshiyuki Takahashi; Seiji Kojima; Tomoki Naoe; Shinichi Esaki; Atsushi Kikuta; Akihisa Sawada; Keisei Kawa; Koichi Ohshima; Shigeo Nakamura
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

Review 5.  Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.

Authors:  Sanghui Park; Young H Ko
Journal:  J Dermatol       Date:  2014-01       Impact factor: 4.005

6.  Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.

Authors:  J I Cohen; H Kimura; S Nakamura; Y-H Ko; E S Jaffe
Journal:  Ann Oncol       Date:  2009-06-10       Impact factor: 32.976

7.  Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma.

Authors:  Leticia Quintanilla-Martinez; Cecilia Ridaura; Florian Nagl; Marimar Sáez-de-Ocariz; Carola Durán-McKinster; Ramon Ruiz-Maldonado; Georgia Alderete; Peter Grube; Carmen Lome-Maldonado; Irina Bonzheim; Falko Fend
Journal:  Blood       Date:  2013-08-27       Impact factor: 22.113

8.  Hydroa-like lymphoma with CD56 expression.

Authors:  Katherine Doeden; Hernan Molina-Kirsch; Edgar Perez; Roger Warnke; Uma Sundram
Journal:  J Cutan Pathol       Date:  2007-11-01       Impact factor: 1.587

9.  Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children.

Authors:  Zigang Xu; Shi Lian
Journal:  Pediatr Dermatol       Date:  2010 Sep-Oct       Impact factor: 1.588

10.  Cutaneous T-cell lymphoma in asians.

Authors:  Min Soo Jang; Dong Young Kang; Jong Bin Park; Sang Tae Kim; Kee Suck Suh
Journal:  ISRN Dermatol       Date:  2012-07-15
View more
  5 in total

1.  Clinicopathological analysis of the hydroa vacciniforme-like lymphoproliferative disorder with natural killer cell phenotype compared with cutaneous natural killer T-cell lymphoma.

Authors:  Guan-Nan Wang; Yong Cui; Wu-Gan Zhao; Ling Li; Xu-Dong Zhang; Yu Chang; Xian-Zheng Gao; Ye Li; Ming-Zhi Zhang; Wen-Cai Li
Journal:  Exp Ther Med       Date:  2018-09-19       Impact factor: 2.447

2.  The face of CD4+ Hydroa Vacciniforme-Like Lymphoproliferative Diseases: The Shadow of Systemic T-Cell Lymphoma.

Authors:  Young Jae Kim; Myoung Eun Choi; Woo Jin Lee; Sung Eun Chang; Jee Ho Choi; Mi Woo Lee
Journal:  Ann Dermatol       Date:  2019-07-01       Impact factor: 1.444

Review 3.  Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.

Authors:  Manli Jiang; N Nora Bennani; Andrew L Feldman
Journal:  Expert Rev Hematol       Date:  2017-01-29       Impact factor: 2.929

4.  Case report: Cellular therapy for hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection.

Authors:  Elżbieta Grześk; Sylwia Kołtan; Anna Dąbrowska; Anna Urbańczyk; Jadwiga Małdyk; Bogdan Małkowski; Tomasz Bogiel; Robert Dębski; Krzysztof Czyżewski; Mariusz Wysocki; Jan Styczyński
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

Review 5.  Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases in Chinese Mainland.

Authors:  Junhong Ai; Zhengde Xie
Journal:  Front Pediatr       Date:  2018-10-09       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.